CIK 0001023024
- Large accelerated filer
ANI PHARMACEUTICALS INC
Sign in to watch- Ticker
- ANIP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 582301143
- Phone
- +1 609-759-1810
- Business address
- 104 CARNEGIE CENTER DRIVE SUITE 300, PRINCETON, NJ, 08540
- Former names
- BIOSANTE PHARMACEUTICALS INC, BEN ABRAHAM TECHNOLOGIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,975,156
- in 10 filings, $2.0M under 10b5-1 plans
Net −$1,975,156. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-03-19 | PRZYBYL ARTHUR President and CEO | Sale | −2,823 | $63.51 | $179K | 205,076 |
| 2019-03-19 | PRZYBYL ARTHUR President and CEO | Exercise or conversion · Stock Options | −2,823 | 35,625 | ||
| 2019-03-18 | PRZYBYL ARTHUR President and CEO | Sale | −24,802 | $63.53 | $1.6M | 205,076 |
| 2019-03-18 | PRZYBYL ARTHUR President and CEO | Exercise or conversion · Stock Options | −6,375 | 0 | ||
| 2019-03-18 | PRZYBYL ARTHUR President and CEO | Exercise or conversion · Stock Options | −9,375 | 18,750 | ||
| 2019-03-18 | PRZYBYL ARTHUR President and CEO | Exercise or conversion · Stock Options | −9,052 | 38,448 | ||
| 2019-03-13 | Schrepfer Robert W SVP - New Bus Dev & Spec Sales | Exercise or conversion | +4,651 | $33.00 | $153K | 52,493 |
| 2019-03-13 | Schrepfer Robert W SVP - New Bus Dev & Spec Sales | Sale | −4,651 | $64.43 | $300K | 47,842 |
| 2019-03-13 | Schrepfer Robert W SVP - New Bus Dev & Spec Sales | Exercise or conversion · Option to Purchase | −4,651 | 3,846 | ||
| 2019-03-12 | Schrepfer Robert W SVP - New Bus Dev & Spec Sales | Exercise or conversion | +5,642 | $28.76 | $162K | 53,484 |
| 2019-03-12 | Schrepfer Robert W SVP - New Bus Dev & Spec Sales | Sale | −5,642 | $64.44 | $364K | 47,842 |
| 2019-03-12 | Schrepfer Robert W SVP - New Bus Dev & Spec Sales | Exercise or conversion | +1,503 | $33.00 | $50K | 49,345 |
| 2019-03-12 | Schrepfer Robert W SVP - New Bus Dev & Spec Sales | Sale | −1,503 | $64.50 | $97K | 47,842 |
| 2019-03-12 | Schrepfer Robert W SVP - New Bus Dev & Spec Sales | Exercise or conversion · Option to Purchase | −5,642 | 608 | ||
| 2019-03-12 | Schrepfer Robert W SVP - New Bus Dev & Spec Sales | Exercise or conversion · Option to Purchase | −1,503 | 8,497 | ||
| 2018-09-11 | Schrepfer Robert W SVP - New Bus Dev & Spec Sales | Exercise or conversion | +28,688 | $6.60 | $189K | 47,842 |
| 2018-09-11 | Schrepfer Robert W SVP - New Bus Dev & Spec Sales | Exercise or conversion · Option to Purchase | −28,688 | 0 | ||
| 2018-06-06 | Walsh Patrick D Director | Grant or award | +1,800 | 1,800 | ||
| 2018-06-06 | Walsh Patrick D Director | Grant or award · Stock Options | +2,225 | 2,225 | ||
| 2018-06-06 | NASH DAVID Director | Grant or award | +1,800 | 1,800 |
Page 30 of 31 · 601 trades